Raj, R., Kumar, A., Prachi Sood, Kumar, R. and Rana, V. (2023) “Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer”, Journal for Research in Applied Sciences and Biotechnology, 2(3), pp. 55–63. doi: 10.55544/jrasb.2.3.8.